09 October 2024
09 October 2024
Less frequent dosing could provide Eli Lilly鈥檚 Ebglyss room to rival Sanofi and Regeneron鈥檚 blockbuster Dupixent.
The companies will collaborate to hold a global Phase I combination trial of YL201 and Amgen鈥檚 Imdelltra for small cell lung cancer.
The endorsement follows a placebo-controlled study involving 161 adults with PBC.
MOMA is entitled to receive an upfront payment as well as a collaboration fee from Bayer.
ARCH Venture Partners spearheaded the funding round with contributions from a consortium of life sciences investors.
The acquisition by PLG adds valuable expertise to its portfolio, supporting biopharmaceutical companies in drug development.
The authorisation expands the range of clinical uses for Illuccix, distributed by Isologic.
Merging industry-leading business intelligence & award-winning journalism, this is an unrivalled opportunity for engagement with B2B professionals across a network of 40+ leading media websites.
Steer your business strategy with key data and insights from our latest market research reports and company profiles. Not ready to buy? Start small by downloading a sample report first.
Give your business an edge with our leading industry insights.
